Cleared Traditional

K944293 - SABRATEK SABSIL SETS

K944293 is an FDA 510(k) clearance for SABRATEK SABSIL SETS, manufactured by Sabratek Corp.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 202-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
202d
Days
Class 2
Risk

K944293 is an FDA 510(k) clearance for the SABRATEK SABSIL SETS. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Sabratek Corp. (Niles, US). The FDA issued a Cleared decision on March 23, 1995 after a review of 202 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Sabratek Corp. devices

FDA 510(k) Submission Details - K944293

510(k) Number K944293 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 02, 1994
Decision Date March 23, 1995
Days to Decision 202 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
73d slower than avg
Panel avg: 129d · This submission: 202d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 650
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K944293.
SMARTFLOW I ADMINISTRATION SET
K945298 · River Medical, Inc. · Jun 1995
E-Z SET, SAF-T E-Z SET, AND MINICATH INFUSION SETS
K952053 · Becton Dickinson Vascular Access, Inc. · May 1995
LOW VOLUME MULTIPORT
K943770 · B. Braun of America, Inc. · Apr 1995
DESERET(R) I.V. LOOP AND DESERET (R) J LOOP
K950303 · Becton Dickinson Vascular Access, Inc. · Mar 1995
DESERET (R) T-PORT (R) MULTI FLO(TM) AND DESERET (R)PRN ADAPTER
K950304 · Becton Dickinson Vascular Access, Inc. · Mar 1995
E-Z SET(R) AND MINICATH(R) INFUSION SETS
K950302 · Becton Dickinson Vascular Access, Inc. · Mar 1995